Join to view full profile
2160 S 1st Ave"# 101-1740"Maywood, IL 60153
Phone+1 708-216-9000
Fax+1 708-216-9033
Dr. Albain is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1981 - 1984
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1979 - 1981
University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
IL State Medical License 1979 - 2029
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- 7 citationsRace and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.Yara Abdou, William E Barlow, Julie R Gralow, Funda Meric-Bernstam, Kathy S Albain
Journal of the National Cancer Institute. 2025-05-01 - 11 citationsDevelopment and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.Lajos Pusztai, Jess R Hoag, Kathy S Albain, William E Barlow, Salomon M Stemmer
Journal of Clinical Oncology. 2025-03-10 - 15 citationsDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda
Nature Medicine. 2024-12-01
Lectures
- 2013 Breast Cancer Symposium,American Society of Breast Surgeons, San Francisco, California - 9/7/2013
- 35th Annual San Antonio Breast Cancer SymposiumUT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
- 2012 Breast Cancer SymposiumAmerican Society of Clinical Oncology(ASCO), San Francisco, California - 9/13/2012
Press Mentions
RSClin Tool N+ Enhances Breast Cancer Risk EstimatesJanuary 23rd, 2025- Loyola University Chicago’s Kathy Albain, MD to Receive Prestigious National Award for Pioneering Breast Cancer ResearchJune 3rd, 2022
Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer DoctorsNovember 6th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: